外科输血风险预测模型的国家多机构验证
本研究利用2019年美国外科医师学会NSQIP数据,在414家医院的1,000,927例手术中评估S-PATH模型的区分度。汇总AUROC在模型调优前为0.910(95%CI 0.904至0.916),调优后为0.925(95%CI 0.919至0.931)。S-PATH表现出优异的区分性能,但各医院间存在变异,且医院层面特征未能很好解释该变异。
要点
- S-PATH在414家医院1,000,927例手术中验证,汇总AUROC调优前0.910、调优后0.925。
- 各医院AUROC中位数0.900(四分位距0.849至0.944),存在院间变异。
- 所研究的医院层面特征与模型AUROC之间无统计学显著关系。
核心结论
- S-PATH表现出优异的区分性能,但各医院间存在变异,且该变异未能被所研究的医院层面特征很好解释。
- 结果凸显S-PATH作为可推广的外科输血风险预测工具的可行性。
研究设计与样本
- 本研究使用2019年美国外科医师学会NSQIP数据文件进行。
- 在每家参与医院评估S-PATH性能,分别在有和无医院特异性模型调优的情况下进行。
- 采用线性回归评估医院特征与受试者工作特征曲线下面积(AUROC)之间的关系。
主要发现
- 共评估来自414家医院的1,000,927例手术病例。
- 汇总AUROC在无模型调优时为0.910(95%CI 0.904至0.916),在有模型调优时为0.925(95%CI 0.919至0.931)。
- AUROC在各医院间存在变异(中位数0.900,四分位距0.849至0.944)。
- 所研究的医院层面特征与模型AUROC之间未发现统计学显著关系。
局限性
- 各医院间存在变异,且该变异未能被所研究的医院层面特征很好解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate estimation of surgical transfusion risk is important for many aspects of surgical planning, yet few methods for estimating are available for estimating such risk. There is a need for reliable validated methods for transfusion risk stratification to support effective perioperative planning and resource stewardship. STUDY DESIGN: This study was conducted using the American College of Surgeons NSQIP datafile from 2019. S-PATH performance was evaluated at each contributing hospital, with and without hospital-specific model tuning. Linear regression was used to assess the relationship between hospital characteristics and area under the receiver operating characteristic (AUROC) curve. RESULTS: A total of 1,000,927 surgical cases from 414 hospitals were evaluated. Aggregate AUROC was 0.910 (95% CI 0.904 to 0.916) without model tuning and 0.925 (95% CI 0.919 to 0.931) with model tuning. AUROC varied across individual hospitals (median 0.900, interquartile range 0.849 to 0.944), but no statistically significant relationships were found between hospital-level characteristics studied and model AUROC. CONCLUSIONS: S-PATH demonstrated excellent discriminative performance, although there was variation across hospitals that was not well-explained by hospital-level characteristics. These results highlight the S-PATH's viability as a generalizable surgical transfusion risk prediction tool.
引用
- Lou SS, Liu Y, Cohen ME, et al. National Multi-Institutional Validation of a Surgical Transfusion Risk Prediction Model. J Am Coll Surg. 2023. PMID: 37737660. doi:10.1097/XCS.0000000000000874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。